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Background: Pathogen recognition drives host defense towards viral infections. Specific groups rather than single
members of the protein family of pattern recognition receptors (PRRs) such as membrane spanning Toll-like
receptors (TLRs) and cytosolic helicases might mediate sensing of replication intermediates of a specific virus
species. TLR7 mediates host sensing of retroviruses and could significantly influence retrovirus-specific antibody
responses. However, the origin of efficient cell-mediated immunity towards retroviruses is unknown. Double-stranded
RNA intermediates produced during retroviral replication are good candidates for immune stimulatory viral products.
Thus, we considered TLR3 as primer of cell-mediated immunity against retroviruses in vivo.
Results: Infection of mice deficient in TLR3 (TLR3−/−) with Friend retrovirus (FV) complex revealed higher viral loads
during acute retroviral infection compared to wild type mice. TLR3−/− mice exhibited significantly lower expression
levels of type I interferons (IFNs) and IFN-stimulated genes like Pkr or Ifi44, as well as reduced numbers of activated
myeloid dendritic cells (DCs) (CD86+ and MHC-II+). DCs generated from FV-infected TLR3−/− mice were less capable of
priming virus-specific CD8+ T cell proliferation. Moreover, cytotoxicity of natural killer (NK) cells as well as CD8+ T cells
were reduced in vitro and in vivo, respectively, in FV-infected TLR3-/- mice.
Conclusions: TLR3 mediates antiretroviral cytotoxic NK cell and CD8+ T cell activity in vivo. Our findings qualify TLR3 as
target of immune therapy against retroviral infections.
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The host immune system offers a variety of different innate
receptors to sense invading viruses. These pattern recog-
nition receptors (PRR) recognize pathogen-associated mo-
lecular pattern (PAMPs), which are highly conserved
molecular structures produced by pathogens but not by
the host cells. One important family of PRRs includes the
Toll-like receptors (TLRs) that span cell or endosomal
membranes. The latter include TLR3, TLR7/8 and TLR9
which recognize double-stranded RNA (dsRNA), single-
stranded RNA or CpG-containing DNA, respectively
(reviewed in [1]). Cytosolic PRRs such as cyclic GMP-
AMP synthase (cGAS), retinoic acid inducible gene I
(RIG-I) and Melanoma Differentiation-Associated pro-
tein 5 (MDA5) also sense replication intermediates of* Correspondence: Kathrin.Gibbert@uni-due.de
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unless otherwise stated.numerous viruses [2-4]. Virus sensing PRRs principally
mediate induction of type I interferon (IFN) production
and thus expression of interferon-stimulated genes to
elicit an antiviral state in the cell. Many viruses have de-
veloped mechanisms to evade their host sensors resulting
in impaired host immunity (reviewed in [5]). Redundancy
in virus recognition, namely employment of a specific
set of multiple PRRs, prevents viral escape from host
surveillance.
Studies in vitro revealed that multiple PRRs such as
DC-SIGN, TLR7/8, TLR9, cGAS and TRIM5α sense ret-
roviruses including HIV and SIV (reviewed in [2,6-10]).
However, in vivo studies determining their impact in
directing antiretroviral innate and adaptive immune re-
sponses remains limited. Using knockout mice, myeloid
differentiation primary response 88 (MyD88) and TLR7-
dependent viral sensing were previously shown as critical
for the development of neutralizing antibody responses
against murine leukemia virus (MuLV) infections [11,12].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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depended on the MyD88-TLR7 pathway [11,12]. The im-
pact of innate sensing mechanisms on Natural Killer (NK)
cell responses, which are also critical for antiretroviral im-
munity [13,14], remains unknown.
In this report, we investigated whether the dsRNA
sensor TLR3 [15] is involved in retrovirus sensing. Du-
plex formation of retroviral RNA prior to reverse tran-
scription may occur during retroviral life cycle [16] and
higher order dsRNA structures like stem loops located in
retroviral long-terminal repeats were described [17,18].
To investigate the impact of TLR3 during retroviral in-
fections in vivo, we used the Friend Retrovirus (FV)
mouse model. The FV complex is comprised of two ret-
roviruses: the replication-competent helper virus called
Friend murine leukemia virus (F-MuLV), which is non-
pathogenic in adult mice, and the replication-defective,
pathogenic spleen focus-forming virus (SFFV) [19]. FV
induces erythroleukemia in susceptible mice. In con-
trast, resistant strains, such as the C57BL/6 mice that
were used in the current study, mount potent immune
responses during acute infection to recover from disease
[20]. Our findings provide evidence that TLR3 mediates
retroviruses sensing which impacts early cellular anti-
retroviral immune response in vivo.
Results
Increased viremia in TLR3−/− mice
Deletion of MyD88 in mice did not result in a significant
increase in acute FV viremia [11,12], suggesting the
existence of alternative sensing pathways. Since TLR3 is ac-
tivated through TIR-domain-containing adapter-inducing
interferon-β (TRIF) [21-23], we tested if TLR3 is involved
in immune recognition of retroviruses. Thus, we infected
wild type mice (TLR3+/+) and mice deficient in TLR3
(TLR3−/−) with FV and analyzed the viral loads at days 4
and 10 post infection. At both time points, a significant
increase in viral loads was detected in TLR3−/− miceFigure 1 Viral loads in FV-infected TLR3−/− and TLR7−/− mice. TLR3+/+
in the spleen were determined by infectious center assay at days 4 (A) and
TLR7−/− and TLR7+/+ mice at 7 dpi were measured by qPCR (C). At least fiv
values are indicated by bars and dots + SEM. Statistically significant differen
* for p < 0.05.(Figure 1). At the earlier time point the mean viral burden
was up to 4 times higher in TLR3−/− compared to wild type
mice (Figure 1A) and the effect was even stronger at 10
dpi (>18-fold; Figure 1B). In contrast, TLR7 deficiency in
mice did not impact acute FV infection (Figure 1C; 7 dpi).
These data indicate that TLR3 sensing contributes to im-
mune control of FV during the acute phase of infection.
Impaired DC activation in FV-infected TLR3−/− mice
As TLR3 is mainly expressed by myeloid DCs (mDCs)
and macrophages (reviewed in [24,25]), but not plasma-
cytoid DCs or T cells, we analyzed the impact of TLR3
sensing on the activation and maturation of mDCs and
macrophages during acute FV infection (4 dpi). Firstly,
we measured if the expression level of this receptor is
up-regulated in mDCs during FV infection. As depicted
in Figure 2A, Tlr3 mRNA was detectable in mDCs of
both uninfected, as well as FV-infected mice, whereas
the relative expression levels did not differ significantly.
As downstream signaling of TLR3 leads to the induction
of type I IFN and subsequent expression of interferon-
stimulated genes (ISG), we analyzed antiviral gene ex-
pression during acute FV infection in TLR3−/− and
TLR3+/+ mice. Therefore, we isolated total mRNA from
mDCs of FV-infected TLR3−/− and TLR3+/+ mice and
analyzed the expression of specific ISGs (Pkr, Ifi44) as
well as the early type I IFNs (Ifn-a4, Ifn-b). Expression
levels of all of the 4 mRNAs analyzed were increased
during FV-infection compared to uninfected controls
(data not shown), however mDCs of FV-infected TLR3−/−
mice had reduced expression levels in comparison to
those of infected TLR3+/+ mice (Figure 2B). The overall
expression level of type I IFNs during FV infection in wild
type mice was quite low which is in line with previous
data from our group [26,27]. As the total numbers
of mDCs in the spleen did not vary significantly in
FV-infected TLR3+/+ and TLR3−/− mice (data not shown),
we next analyzed the activation of mDCs which wasand TLR3−/− mice were infected with 20,000 SFFU of FV and viral loads
10 (B) post infection. In addition, plasma viral loads from FV-infected
e mice per group were analyzed. Individual percentages and mean
ces between FV-infected TLR3+/+ and TLR3−/− mice are indicated by
Figure 2 Phenotypic analysis of splenic DCs in FV-infected mice. TLR3+/+ and TLR3−/− mice were infected with 20,000 SFFU of FV. At 4 dpi
splenic DCs were isolated and analyzed for Tlr3 mRNA expression (A) and mRNA expression of Pkr, Ifi44, Ifn-a4 and Ifn-b (B). Splenic DCs (CD11c+
CD11b+) were also analyzed by flow cytometry. Surface expression of the costimulatory molecule CD86 (C, D) and MHC-II (E, F) were determined.
Uninfected TLR3+/+ and TLR3−/− mice were used as controls (white bars). A minimum of nine mice per FV-infected group were analyzed and the
individual values are indicated by bars and dots + SEM. Experiments were repeated at least twice. Statistically significant differences between the
groups are indicated by * for p < 0.05, ** for p < 0.01 and *** for p < 0.001.
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molecule CD86 and major histocompatibility complex
class II (MHC-II). Although the overall activation of
mDCs during FV infection was low, mDCs were sig-
nificantly higher activated during FV infection than in
uninfected control mice (TLR3−/− or TLR3+/+ mice). In
FV-infected mice a significantly reduced percentage of
CD86+ mDCs was detected in TLR3−/− mice in compa-
rison to TLR3+/+ mice (Figure 2C) and a reduced mean
fluorescence intensity of CD86 on mDCs of FV-infected
TLR3−/− mice was found (Figure 2D). While infected
TLR3−/− mice did not have lower percentages of MHC-II+
mDCs compared to wild type mice (Figure 2E), the surface
expression levels of MHC-II on these cells were signifi-
cantly decreased in FV-infected TLR3−/− mice (Figure 2F).
In contrast, the absolute numbers of macrophages in the
spleen of FV-infected wild type and TLR3−/− mice, aswell as their activation status, did not differ (data not
shown). Thus, TLR3 enhanced expression of type I IFNs
and antiviral ISGs as well as activation of mDCs upon
FV infection.
NK cell cytotoxicity depends on TLR3
Since mDCs bridge pathogen recognition and immune
responses, we investigated effector functions of specific
immune cell populations. As TLR3 already had an im-
pact on viral loads at 4 dpi (Figure 1A), we analyzed the
numbers and effector functions of NK cells at this early
time point [14]. We did not find an increase in total num-
bers of NK cells (NK1.1+ CD49b+ CD3−) or percentages of
activated (CD69) NK cells in the spleen of FV-infected
mice compared to uninfected control mice (Figure 3A,
and data not shown). Moreover, no significant difference
in NK cell activation was observed between FV-infected
Figure 3 Effector functions of NK cells. TLR3+/+ and TLR3−/− mice were infected with 20,000 SFFU of FV. At 4 dpi numbers of NK cells (CD3− CD49b+
NK1.1+) in the spleen of FV-infected or naive mice were analyzed by flow cytometry (A). At least six mice of minimum two independent experiments
were used and the mean values are shown by bars and dots + SEM. The cytotoxic potential of splenic NK cells was analyzed in an in vitro NK cell
cytotoxicity assay. NK cells were isolated from spleens of FV-infected TLR3+/+ and TLR3−/− mice (B). FV-derived tumor cells (FBL-3) were stained with
CFSE and co-cultured with isolated NK cells at different effector-target ratio of 50:1 to 6:1 for 24 h. At least four mice were used for the analysis.
Statistically significant differences between the groups of infected TLR3+/+ and TLR3−/− mice are indicated by * for p < 0.05.
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an in vitro cytotoxicity assay, we observed a significant de-
crease in killing of FV-derived tumor cells (FBL-3) by NK
cells isolated from FV-infected TLR3−/− mice in contrast
to NK cells from wild type mice (Figure 3B). NK cells
from FV-infected wild type mice were twice as effective in
killing target cells as those from TLR3−/− mice. Their
killing capacity was very low, at comparable levels of NK
cells from naive control mice. Thus, TLR3 is required for
cytotoxic NK cell responses during acute FV infection.
Impaired T cell responses in TLR3-deficient FV-infected
mice
We next investigated T cell responses at 10 days post in-
fection, when viral loads in TLR3−/− mice were promi-
nently higher than in wild type mice (Figure 1B). Firstly,
we analyzed if DCs from FV-infected TLR3−/− mice had
an altered capacity to stimulate CD8+ T cell proliferation
in vitro. We generated bone marrow (BM) derived DCs
isolated from FV-infected TLR3−/− and TLR3+/+ mice
and loaded these with a FV-specific CD8+ T cell epitope
peptide. Afterwards, peptide-loaded BM-DCs were co-
cultured with CFSE-labeled FV-specific TCR transgenic
CD8+ T cells and T cell proliferation was measured. As
shown in Figure 4A, T cell stimulation with BM-DCs
generated from TLR3−/− mice resulted in lower numbers
of proliferating CD8+ T cells (fewer CD8+ T cell prolifer-
ation cycles) than those of wild type mice. This decrease
was also seen in a representative histogram in Figure 4B
showing that the proportion of cells particularly in the
fourth daughter population (left peak; generation 4) was
strongly reduced in cultures with BM-DCs generated
from TLR3−/− mice. The data implicate TLR3 in priming
of FV-specific CD8+ T cells.
To monitor effector T cell responses during acute FV
infection in TLR3-deficient and wild type mice, we in-
fected these mice with 20,000 SFFU of FV. At 10 dpi,
splenocytes were analyzed for CD4+ and CD8+ T cell re-
sponses. We did not detect a difference in the overallpercentage of activated (CD43+ CD62L−) CD4+ T cells
(Figure 5A). However, significantly lower numbers of
virus-specific CD4+ T cells were detected in FV-infected
TLR3−/− mice (Figure 5B). We observed no difference in
the expression of IFN-γ (Figure 5C), IL-2 (Figure 5D) or
TNF-α (Figure 5E) indicating that CD4+ T cell functions
did not depend on TLR3 during acute FV infection.
Next, we analyzed CD8+ T cells, which are key players in
anti-FV immunity [28,29]. In comparison to TLR3-
deficient mice, wild type mice had significantly higher
percentages of activated (CD43+, Figure 5F) as well as
virus-specific CD8+ T cells measured by tetramer stain-
ing (Figure 5G). To address if the impaired activation of
the CD8+ T cells correlated with reduced cytotoxic ef-
fector functions and consequently higher viral loads
(Figure 1), we performed an in vivo CTL assay. We ob-
served a significantly higher killing of FV peptide-
labeled target cells in wild type mice (mean: 85%) in
contrast to TLR3−/− mice (mean: 62.5%; Figure 5H).
These results demonstrate that TLR3 is essential for the
induction of potent cytotoxic CD8+ T cell effector func-
tions during acute FV infection.
Discussion
Efficient sensing by the innate immune system is the
first step towards an effective antiviral immune response.
In an effort to determine which innate sensing pathways
are critical for retrovirus infections in vivo, mice defi-
cient in various innate sensors were infected with mur-
ine retroviruses such as MuLV. Previously, it was shown
that TLR7 and MyD88 were required for a potent anti-
retroviral humoral immune response [11,12]. However,
T cell responses were only partially affected by MyD88
signaling, and no data exists on sensors required for NK
cell activity. Here, we demonstrate for the first time that
TLR3 sensing is involved in cytotoxic T cell and NK cell
responses during acute FV infection.
Interestingly, no differences in viral loads were ob-
served between wild type and MyD88-deficient mice
Figure 4 Proliferation of FV-specific CD8+ T cells in vitro. TLR3+/+ and TLR3−/− mice were infected with 20,000 SFFU of FV. At 4 dpi bone
marrow cells were isolated and cultured for 7 days to obtain BM-DCs. BM-DCs were loaded with FV GagL peptide and co-cultured with CFSE-labeled
FV-specific CD8+ T cells for 3 days. Proliferation of transgenic CD8+ T cells was determined by flow cytometry by loss of CFSE dye as calculated
numbers of proliferating cells (A) or a representative histogram showing the amount of cells in each generation (B). A minimum of six mice were used
for analysis. At least two independent experiments were performed. Significant differences between the groups are indicated by * for p < 0.05.
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Our data showing that TLR7 does not impact acute FV
infection (see Figure 1C) is consistent with this finding,
but contrasts recent data from the same group [30]. We
hypothesize that the lack or inconsistent impact of
TLR7/MyD88 on acute FV infection may reflect the fact
that the neutralizing antibody responses do not play a
significant role in inhibiting FV at the earliest infection
time points [31]. Notably, at later time points (starting
2 weeks post infection) viral loads were increased in
MyD88−/− mice, consistent with a weakened humoral
immune response. We recently provided evidence that
NK cell responses could significantly inhibit acute FV
replication in vivo [14]. Thus, our findings showing en-
hanced acute FV replication in TLR3−/− mice are con-
sistent with a strong impact of TLR3 on cytotoxic NK
cell responses. TLR3 is strongly expressed by mDCs,
whereas its expression is weak in murine B cell subsets
[32]. In contrast, TLR7 is highly expressed by follicular
B, marginal zone B, Peyer´s patch B and B-1B cells and
the expression level in mDCs is rather low [32]. This
may explain that TLR7 is required for efficient antibody
responses [11,12] as it might directly influence B cell re-
sponses and not NK or T cell responses.
Other known innate sensors for retroviral infections
are cGAS [2], DC-Sign [6], TLR9 [33] and zinc-finger
antiviral protein [34]. They were all observed to be im-
portant for induction of type I IFN by retroviruses, but
their influence on cellular or humoral immune responses
has not been investigated so far. Antiviral immune
responses can be affected by many sensors, which were
described for other virus infections. This depends on the
host cell type and on the time point of the infection.
Especially TLRs are not ubiquitously expressed, but
rather by specific immune cells like mDCs, pDCs,macrophages, B cells and others [35-37]. Other PRRs
like MDA5 or Rig-I are found in the cytosol of almost
every cell type making them efficient general sensors for
viral infections. For influenza virus infection various
PRRs were shown to be required for efficient induction
of anti-viral immune responses. Influenza virus infection
is sensed by many different PRRs (TLR3, TLR7 and Rig-I)
(reviewed in [38]), and they all have distinct influences
on the cellular and humoral immune responses against
the virus. It was shown that TLR3, TLR7 and MyD88
signaling is not required for efficient T responses during
influenza infection [39,40], but both TLR7 and MyD88
are critical for B cell responses during influenza infec-
tion [40]. Koyama and colleagues investigated that Rig-I
is also not needed for a potent CD8+ T cell response,
whereas B cells and CD4+ T cells require MyD88 and
Rig-I [39]. West Nile virus (WNV) vaccination studies
revealed that MyD88 and TLR3 are both required for
efficient humoral immune responses [41], and during a
WNV infection Rig-I and MDA5 [42-44], as well as
TLR3 and TLR7 [45,46] are involved in immune recog-
nition. Infection with Theiler`s murine encephalomyeli-
tis virus requires sensing of both TLR3 and MDA5
[47,48]. Tabeta and colleagues reported that during
mouse cytomegalovirus infection deficiency of TLR3
and TLR9 increases the infection due to reduced type I
IFN secretion and NK cell activation [49]. This demon-
strates that in many viral infections immune responses
are initiated by various sensors and distinct PRRs have
unique roles during viral defense.
Toll-like receptor 3 recognizes double-stranded RNA
during viral infections [15]. Retroviruses consist of two
single-stranded RNA strands which are entwined within
the core. Together with the viral proteins they build a
dimeric RNA complex [50]. These RNA strands form
Figure 5 FV-specific CD4+ and CD8+ T cell responses in
FV-infected TLR3+/+ and TLR3−/− mice. TLR3+/+ and TLR3−/−
mice were infected with 20,000 SFFU of FV. CD4+ and CD8+ T cells were
analyzed at 10 dpi by flow cytometry. Percentages of activated
(CD43+ CD62L−, A) CD4+ T cells were determined. For the analysis
of virus-specific CD4+ T cells (B) splenocytes were stained with MHC
class II-antibody tetramers specific for F-MuLV env fn20. To analyze the
function of CD4+ T cells, the intracellular expression of IFN-γ
(C), IL-2 (D) and TNF-α (E) was measured in activated effector CD4+
T cells. Percentages of activated (CD43+, F) CD8+ T cells and
virus-specific effector CD8+ T cells (G), which are specific for the FV
GagL epitope stained for GagL class I tetramers, were analyzed by flow
cytometry. Uninfected TLR3+/+ and TLR3−/− mice were used as
controls (white bars). At least five mice per group were analyzed and
the mean value for each group is indicated by bars and dots.
At least 2 independent experiments were performed. Statistical
differences between the groups are indicated by * for p < 0.05, ** for
p < 0.01 and *** for p < 0.001. (H) Splenocytes from naive mice were
loaded with the FV-specific DbGagL peptide and labeled with CFSE.
Target cells were injected intravenously into naive or FV-infected TLR3
+/+ and TLR3−/− mice. Two hours after transfer, donor cells from spleen
were analyzed. The figure shows the percentage of target cell killing in
the spleen. Two independent experiments with three mice per group
were performed and mean values are shown by bars. Differences
between both groups are indicated by ** for p < 0.01.
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might be targeted by TLR3 [17,18,51-53]. A recent study
could show that TLR3 recognizes stem structures in
single-stranded viral RNA [54] which indicates that
TLR3 is a potential immune sensor of retroviruses.
In an earlier study we have used a synthetic ligand for
TLR3 (polyinosinic:polycytidylic acid, poly I:C) to treat
mice during acute FV infection [55]. Stimulation of
TLR3 resulted in a significant reduction in viral loads
and prevented virus-induced splenomegaly as well as
the onset of lethal erythroleukemia. We showed that
CD8+ T cell responses and especially their cytotoxicity
(CD107a, GzmB expression) were improved by trig-
gering TLR3 [55]. However, TLR3 stimulation alone can
still not mediate complete viral clearance in retro-
viral infections leading to the development of chronic
infections.
Others demonstrated that stimulation of macrophages
with poly I:C reduces HIV-1 infection in vitro [56-59]
which depends on the expression of microRNA-155
[60]. Lentiviral vectors [61] as well as in vitro transcribed
HIV-1 gag mRNA [62] were shown to be sensed by
TLR3. Another interesting observation reported that a
common polymorphism in the human TLR3 mediates
protection from HIV-1 by increased activation PBMCs
and the production of the proinflammatory cytokines
IL-6 and CCL-3 [63]. This indicates that targeting TLR3
during retroviral infections might improve host immune
response and thus reduce viral loads which makes TLR3
as a potential target for antiretroviral immunotherapies.
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In summary, we used TLR3−/− mice to investigate the
role of TLR3 in antiretroviral immunity utilizing the
Friend retrovirus mouse model. Viral loads were signifi-
cantly increased in these mice revealing that TLR3 par-
ticipates in anti-FV immunity during acute infection.
Specifically the cytotoxicity of NK cells and CD8+ T cells
was significantly impaired in TLR3−/− mice as compared
to those of wild type controls. Triggering TLR3 activa-
tion might stimulate cytotoxic effector cells to eliminate




Seven to nine weeks old female C57BL/6 mice (TLR3+/+,
TLR7+/+, Charles River Laboratories, Germany) were used
for the experiments. Experiments were also done with
TLR3−/− mice [15] and TLR7−/− [64] (Jackson Laboratories,
USA) backcrossed more than 10 times on C57BL/6 back-
ground. All mice were treated in accordance with the regu-
lations and guidelines of the institutional animal care and
use committee of the University of Duisburg-Essen.
Virus and viral infection
The FV stock used in these experiments was FV complex
containing B-tropic Friend murine leukemia helper virus
and polycythemia-inducing spleen focus-forming virus.
The stock was prepared as a 15% spleen cell homogenate
from BALB/c mice infected 14 days previously with
3000 spleen focus-forming units (SFFU). Mice were
injected intravenously with 0.1 ml phosphate-buffered
saline containing 20,000 SFFU of FV. The virus stock
did not contain lactate dehydrogenase-elevating virus.
Detection of FV-infected cells
Infectious centers (IC) were detected by 10-fold dilu-
tions of single-cell suspensions onto Mus dunnis cells.
Cultures were incubated for 3 days, fixed with ethanol,
stained with F-MuLV envelope-specific monoclonal anti-
body 720 and developed with peroxidase-conjugated
goat anti-mouse antibody and aminoethylcarbazol to de-
tect foci [65].
Plasma viral load quantification
FV plasma viral RNA loads were measured by real-time
PCR as previously described [66].
RNA isolation
Splenic DCs were separated by MACS technology (Miltenyi
Biotec) and their total RNA was isolated using TRIzol re-
agent (Life Technologies) and Pure Link RNA Micro Kit
(Life Technologies). Isolated RNA was dissolved in RNase-
free water and stored at −80°C.Real time-PCR
Real time-PCR analysis for the quantification of Pkr, Ifn-
a4, Ifn-b, Ifi44 and Tlr3 mRNA was performed using
Power SYBR Green RT-PCR kit (Life Technologies) and
Quanti Tect Primer assays (Qiagen). Primer sequences
(Biomers) for β-actin were as follows: 5’-aaatcgtgcgtga-
catcaaa-3’, 5’-caagaaggaaggctggaaaa-3’. The quantitative
mRNA levels were performed by using StepOne Soft-
ware v2.3 (Life Technologies) and were normalized to
β-actin mRNA expression levels.
Generation and culture of myeloid DCs from bone
marrow cells and antigen-specific T cell proliferation
Bone marrow-derived DCs were generated as described
before [67]. BM-DCs from 4 dpi infected TLR3+/+ and
TLR3−/− mice were left untreated or loaded with 0.1 μg/mL
FV antigen (FV GagL peptide (85–93)). Antigen-specific
CD8+ T cells were isolated from TCRtg mice by MACS
technology (Miltenyi Biotec) and stained with CellTrace™
CFSE (Life Technologies). Afterwards, 2.5×105 FV-specific
CD8+ T cells were co-cultured with 0.5×105 BM-DCs.
After 3 days, proliferation of CD8+ T cells was assessed by
flow cytometry as loss of CellTrace™ CFSE dye. Numbers
of proliferating CD8+ T cells were calculated by the fol-
lowing formula:
n proliferating cellsð Þ ¼ n G1ð Þ
2
þ n G2ð Þ
4
þ n G3ð Þ
8
þ n G4ð Þ
16
Cell surface and intracellular staining by flow cytometry
Cell surface staining was performed using the following
antibodies: anti-CD11b (M1/70, Miltenyi Biotec), anti-
CD11c (N418, BioLegend) anti-CD3 (17A2, eBioscience),
anti-CD49b (DX5, eBioscience), anti-CD69 (H1.2 F3,
eBioscience), anti-CD86 (GL-1, BioLegend), anti-MHC-II
(M5/114.15.2, Miltenyi Biotec), anti-NK1.1 (PK136, BD
Bioscience). Dead cells were excluded from analysis (posi-
tive for fixable viability dye, eBioscience). For detection of
activated T cells splenocytes were stained with anti-CD4
(GK1.5, eBioscience), anti-CD8 (53–6.7, eBioscience),
anti-CD43 (1B11, BioLegend) and anti-CD62L (MEL-14,
eBioscience). Intracellular IFN-γ (XMG1.2, Miltenyi
Biotec), IL-2 (JES6-5H4, Miltenyi Biotec) and TNF-α (MP6-
XT22, BioLegend) staining was performed as described
[28,29]. Data were acquired on LSR II flow cytometer (BD
Bioscience) and analyses were performed using FACSDiva
(BD Bioscience) and Flow Jo (Tree Star, USA) software.
Tetramers and tetramer staining
Tetramer stainings were performed as described pre-
viously [13].
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In vitro NK cell cytotoxicity assay was performed using
1 × 104 CFSE stained FBL-3 tumor cells and varying num-
bers of isolated NK cells from spleen of naive or FV-
infected mice by MACS technology (Miltenyi Biotec). The
cytotoxic assay was performed in 96-well U-bottom plates.
The cells were co-incubated for 24 hours in a humidified
5% CO2 atmosphere at 37°C. Cells were washed once, re-
suspended in buffer containing 7-aminoactinomycin D to
exclude dead cells and analyzed by flow cytometry.
In vivo cytotoxicity assay
The in vivo cytotoxicity assay was performed as pre-
viously described [28]. Labeled target cells were trans-
ferred into naive or FV-infected TLR3+/+ or TLR3−/− mice
at day 10 post infection.
Statistical analyses
Statistical analyses and graphical presentations were
computed with Graph Pad Prism version 6. Two-group
comparisons were done using 2-tailed unpaired Student’s
t test. Analyses including several groups were tested
using Kruskal-Wallis one-way analysis of variance on
ranks and Dunn’s multiple comparison test (non-para-
metric distribution) or the ordinary one-way ANOVA
and Bonferroni's multiple comparisons test (parametric
distribution). P values less than 0.05 were considered
statistically significant.
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